MDBI.F Stock Overview
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
TrivarX Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.0069 |
| 52 Week High | AU$0.025 |
| 52 Week Low | AU$0.0021 |
| Beta | 0.92 |
| 11 Month Change | -4.98% |
| 3 Month Change | 227.14% |
| 1 Year Change | n/a |
| 33 Year Change | -93.75% |
| 5 Year Change | -96.27% |
| Change since IPO | -99.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDBI.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -5.0% | 2.0% | 2.2% |
| 1Y | n/a | 8.3% | 31.7% |
Return vs Industry: Insufficient data to determine how MDBI.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how MDBI.F performed against the US Market.
Price Volatility
| MDBI.F volatility | |
|---|---|
| MDBI.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MDBI.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MDBI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | n/a | trivarx.com |
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023.
TrivarX Limited Fundamentals Summary
| MDBI.F fundamental statistics | |
|---|---|
| Market cap | US$4.75m |
| Earnings (TTM) | -US$932.30k |
| Revenue (TTM) | US$577.61k |
8.2x
P/S Ratio-5.1x
P/E RatioIs MDBI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDBI.F income statement (TTM) | |
|---|---|
| Revenue | AU$888.83k |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$888.83k |
| Other Expenses | AU$2.32m |
| Earnings | -AU$1.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0031 |
| Gross Margin | 100.00% |
| Net Profit Margin | -161.41% |
| Debt/Equity Ratio | 0% |
How did MDBI.F perform over the long term?
See historical performance and comparison